get a key
steadybase-$ company BIOA
account_id none on file
legal_name BioAge Labs, Inc.
ticker BIOA
cik 1709941
domain bioagelabs.com
entry_point_account_id none on file
name BioAge Labs Inc.
exchange Nasdaq
sector Health Care
calls 0 filings 4 executives 0 family 0
why_nownone on file
callsnone on file
filings
The increased costs will decrease our net income or increase our net loss, and the increased costs may require us to reduce costs in other areas of our business.

filing / Aug 5, 2026 / receipt

• costs of outside consultants, including their fees and related travel expenses; • costs related to compliance with quality and regulatory requirements; and • payments made under third-party licensing agreements.

filing / Aug 5, 2026 / receipt

The increased costs will decrease our net income or increase our net loss, and the increased costs may require us to reduce costs in other areas of our business.

filing / May 8, 2026 / receipt

• costs of outside consultants, including their fees and related travel expenses; • costs related to compliance with quality and regulatory requirements; and • payments made under third-party licensing agreements.

filing / May 8, 2026 / receipt

executivesnone on file
familynone on file
upcoming
2026-11-05 earnings call scheduled webcast / ir
changesnone on file
mcp_package_hint
steadybase-$